From: Current insight into the regulation of PD-L1 in cancer
Type | Regulators of PD-L1 | Cancer type |
---|---|---|
Transcription factors | MYC | |
BRD4 | ||
STAT3 | ↑T cell lymphoma[37], | |
STAT1 | ||
NF-κB | ↑prostate cancer [44], PC [45] | |
CKD5 | ||
HIF-1α | ||
MLL1 | ↑PC[134] | |
NRF2 | ↑HCC[22] | |
ATF3 | ↑melanoma and NSCLC[55] | |
Epigenetic regulation of PD-L1 | DNA methylation | |
Histone modification | ||
MicroRNAs | shown in Table 1 | |
N6- methyladenosine | ||
LncRNA and circRNA | HOTTIP, SNHG12, EMX2OS- SNHG20-↑esophagus cancer[78] CASC11-↑HCC[80] SNHG14-↑DLBCL[79] NUTM2A-AS1-↑GC[82] Hoxa-AS2-↑nasopharyngeal carcinoma[83] IFITM4P-↑OSCC[84] LncMX1-215-↓HNSCC[85] Hsa_circ_0000190-↑NSCLC[186] HasCircRNA-002178-↑ LUAD[87] CDR1-AS-↑CC[88] | |
PD-L1 regulation at the protein level | Ubiquitination | CC[99], colon cancer[100], melanoma[101, 102, 106], lung cancer[101], esophageal squamous cell carcinoma[105] |
Glycosylation | ||
Phosphorylation | ||
Acetylation | ↓ multiple cancers[117] | |
Palmitoylation | ||
Autophagy | ↓ OC[122] |